RecruitingPhase 3NCT04856488
Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter
Sponsor
Jan Calissendorff
Enrollment
182 participants
Start Date
Nov 18, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess if preoperative treatment with Lugol's solution prior to thyroidectomy can reduce the surgical complications hypoparathyroidism and laryngeal nerve palsy
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Iodine-Potassium Iodide 5%-10% Oral and Topical Solution for people with hyperthyroidism. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGIodine-Potassium Iodide 5%-10% Oral and Topical Solution
Iodine Potassium Iodide 5% oral solution, administered 3 times per day for 10 days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04856488
Related Trials
Natural History of Thyroid Function Disorders
NCT000011591 location
Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
NCT073690631 location
Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
NCT067942031 location
A Clinical Study of Hyperthyroidism in Children
NCT065709671 location